Soleno Therapeutics Statistics

Total Valuation

SLNO has a market cap or net worth of $3.87 billion. The enterprise value is $3.63 billion.

Market Cap	3.87B
Enterprise Value	3.63B

Important Dates

The last earnings date was Wednesday, May 7, 2025, after market close.

Earnings Date	May 7, 2025
Ex-Dividend Date	n/a

Share Statistics

SLNO has 50.39 million shares outstanding. The number of shares has increased by 84.06% in one year.

Current Share Class	50.39M
Shares Outstanding	50.39M
Shares Change (YoY)	+84.06%
Shares Change (QoQ)	+5.13%
Owned by Insiders (%)	1.44%
Owned by Institutions (%)	76.65%
Float	39.91M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	116.26
PB Ratio	16.03
P/TBV Ratio	17.11
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 19.64, with a Debt / Equity ratio of 0.23.

Current Ratio	19.64
Quick Ratio	18.43
Debt / Equity	0.23
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-128.22

Financial Efficiency

Return on equity (ROE) is -105.54% and return on invested capital (ROIC) is -59.51%.

Return on Equity (ROE)	-105.54%
Return on Assets (ROA)	-52.40%
Return on Invested Capital (ROIC)	-59.51%
Return on Capital Employed (ROCE)	-67.51%
Revenue Per Employee	n/a
Profits Per Employee	-$2.15M
Employee Count	92
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +70.48% in the last 52 weeks. The beta is -2.67, so SLNO's price volatility has been lower than the market average.

Beta (5Y)	-2.67
52-Week Price Change	+70.48%
50-Day Moving Average	62.74
200-Day Moving Average	53.01
Relative Strength Index (RSI)	65.03
Average Volume (20 Days)	951,858

Short Selling Information

The latest short interest is 4.16 million, so 8.26% of the outstanding shares have been sold short.

Short Interest	4.16M
Short Previous Month	5.01M
Short % of Shares Out	8.26%
Short % of Float	10.43%
Short Ratio (days to cover)	2.11

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-204.13M
Pretax Income	-65.41M
Net Income	-198.23M
EBITDA	-202.13M
EBIT	-204.13M
Earnings Per Share (EPS)	-$4.65

Full Income Statement

Balance Sheet

The company has $289.95 million in cash and $52.79 million in debt, giving a net cash position of $237.16 million or $4.71 per share.

Cash & Cash Equivalents	289.95M
Total Debt	52.79M
Net Cash	237.16M
Net Cash Per Share	$4.71
Equity (Book Value)	232.26M
Book Value Per Share	4.79
Working Capital	293.18M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$89.32 million and capital expenditures -$212,000, giving a free cash flow of -$89.53 million.

Operating Cash Flow	-89.32M
Capital Expenditures	-212,000
Free Cash Flow	-89.53M
FCF Per Share	-$1.78

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SLNO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-84.06%
Shareholder Yield	-84.06%
Earnings Yield	-5.13%
FCF Yield	-2.32%

Analyst Forecast

The average price target for SLNO is $103.33, which is 34.72% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$103.33
Price Target Difference	34.72%
Analyst Consensus	Strong Buy
Analyst Count	9
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on August 26, 2022. It was a reverse split with a ratio of 0.0666667:1.

Last Split Date	Aug 26, 2022
Split Type	Reverse
Split Ratio	0.0666667:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2